Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-15 00:07 | 2025-07-10 | ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Officer | OPT+S | $22.66 | 1,000 | $22,655 | 23,000 |
| 2025-07-15 04:36 | 2025-07-10 | IRON | Disc Medicine, Inc. | Franchi Jean M. | Officer | SELL | $57.50 | 2,000 | $115,000 | 65,530 |
| 2025-07-14 23:30 | 2025-07-10 | COGT | Cogent Biosciences, Inc. | Fairmount Funds Management LLC | Director | BUY | $9.00 | 2,777,777 | $24,999,993 | 9,003,418 |
| 2025-07-14 15:40 | 2025-07-11 | ANIX | Anixa Biosciences Inc. | KUMAR AMIT | Officer | BUY | $3.15 | 5,000 | $15,750 | 574,925 |
| 2025-07-14 23:36 | 2025-07-10 | CORT | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR | Director | OPT+S | $71.08 | 2,200 | $156,376 | 0 |
| 2025-07-14 23:30 | 2025-07-10 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | Officer | OPT+S | $300.31 | 11,000 | $3,303,394 | 36,781 |
| 2025-07-14 23:11 | 2025-07-14 | ANIP | Ani Pharmaceuticals Inc. | Cook Meredith | Officer | SELL | $64.88 | 400 | $25,952 | 78,945 |
| 2025-07-11 23:30 | 2025-07-09 | NUVL | Nuvalent, Inc. | Pelish Henry E. | Officer | OPT+S | $80.31 | 7,645 | $613,986 | 60,956 |
| 2025-07-12 01:30 | 2025-07-10 | AKRO | Akero Therapeutics, Inc. | Cheng Andrew | Director, Officer | SELL | $51.16 | 30,000 | $1,534,896 | 520,757 |
| 2025-07-12 00:27 | 2025-07-09 | TRDA | Entrada Therapeutics, Inc. | PARMAR KUSH | Director, 10% owner | SELL | $7.50 | 27,000 | $202,554 | 1,093,313 |
| 2025-07-11 23:09 | 2025-07-09 | MRUS | Merus N.V. | Silverman Peter B. | Officer | OPT+S | $55.00 | 23,500 | $1,292,500 | 0 |
| 2025-07-11 23:30 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Officer | OPT+S | $77.78 | 7,969 | $619,850 | 8,509 |
| 2025-07-11 23:30 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Officer | OPT+S | $77.13 | 15,572 | $1,201,062 | 19,209 |
| 2025-07-11 23:31 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Officer | OPT+S | $80.48 | 42,120 | $3,389,754 | 116,915 |
| 2025-07-11 23:48 | 2025-07-09 | IRON | Disc Medicine, Inc. | Quisel John D | Director, Officer | OPT+S | $55.33 | 34,800 | $1,925,526 | 161,828 |
| 2025-07-11 23:59 | 2025-07-09 | AGIO | Agios Pharmaceuticals Inc. | Gheuens Sarah | Officer | OPT+S | $37.99 | 11,914 | $452,601 | 61,271 |
| 2025-07-11 23:30 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Officer | OPT+S | $80.75 | 3,817 | $308,217 | 922 |
| 2025-07-12 01:17 | 2025-07-10 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | SELL | $125.00 | 934 | $116,750 | 46,456 |
| 2025-07-12 00:25 | 2025-07-09 | TRDA | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | 10% owner | SELL | $7.50 | 27,000 | $202,554 | 1,093,313 |
| 2025-07-12 00:50 | 2025-06-02 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Young Caroline | Director | BUY | $4.80 | 84 | $404 | 32,653 |
| 2025-07-12 00:48 | 2025-06-02 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Jones James | Director | BUY | $4.80 | 168 | $807 | 43,336 |
| 2025-07-12 00:46 | 2025-06-02 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth | Director | BUY | $4.83 | 935 | $4,513 | 286,633 |
| 2025-07-12 00:49 | 2025-06-02 | CPIX | CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J | Director, Officer, 10% owner | BUY | $4.80 | 168 | $807 | 5,699,428 |
| 2025-07-12 00:14 | 2025-07-09 | ONC | BeOne Medicines Ltd. | OYLER JOHN | Director, Officer | SELL | $253.38 | 27,802 | $7,044,590 | 0 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | O'Malley Brendan M. | Officer | SELL | $5.86 | 17,428 | $102,053 | 360,817 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | Seshadri Vishwas | Director, Officer | SELL | $5.86 | 69,420 | $406,503 | 1,234,341 |
| 2025-07-10 23:30 | 2025-07-08 | ABEO | Abeona Therapeutics Inc. | Wuchterl Donald A. | Director | SELL | $5.82 | 5,176 | $30,147 | 145,436 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | Charles Faith L. | Director | SELL | $5.86 | 10,738 | $62,879 | 139,094 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | Silverstein Christine Berni | Director | SELL | $5.86 | 13,093 | $76,669 | 120,479 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | Vazzano Joseph Walter | Officer | SELL | $5.86 | 25,411 | $148,799 | 479,168 |
| 2025-07-11 00:15 | 2025-07-08 | OTLC | Oncotelic Therapeutics, Inc. | Trieu Vuong | Director, Officer, 10% owner | BUY | $0.01 | 198,737 | $994 | 93,388,297 |
| 2025-07-11 03:18 | 2025-07-09 | CALC | CalciMedica, Inc. | Roberts Eric W | Director, Officer, 10% owner | BUY | $1.60 | 5,000 | $8,024 | 37,823 |
| 2025-07-11 03:56 | 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | Officer | SELL | $3.53 | 9,522 | $33,649 | 204,229 |
| 2025-07-11 03:52 | 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | HUNT DOUGLAS M | Officer | SELL | $3.53 | 7,817 | $27,624 | 164,894 |
| 2025-07-11 03:49 | 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | AUERBACH ALAN H | Director, Officer, 10% owner | SELL | $3.53 | 47,172 | $166,701 | 7,180,901 |
| 2025-07-10 23:30 | 2025-07-09 | ABEO | Abeona Therapeutics Inc. | Alvino Mark | Director | SELL | $5.86 | 13,093 | $76,669 | 77,252 |
| 2025-07-11 03:56 | 2025-07-09 | KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | Director, Officer | SELL | $15.69 | 32,979 | $517,523 | 369,595 |
| 2025-07-11 03:50 | 2025-07-09 | KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Officer | SELL | $15.69 | 30,250 | $474,698 | 127,939 |
| 2025-07-10 23:17 | 2025-07-08 | ELTP | ELITE PHARMACEUTICALS INC /NV/ | Plassche Douglas | Officer | SELL | $0.58 | 200,000 | $115,800 | 2,300,000 |
| 2025-07-10 02:00 | 2025-07-07 | AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Officer | OPT+S | $51.09 | 12,500 | $638,661 | 167,124 |
| 2025-07-10 02:29 | 2025-07-07 | ELVN | Enliven Therapeutics, Inc. | Patel Anish | Officer | SELL | $19.79 | 6,667 | $131,951 | 296,642 |
| 2025-07-09 23:34 | 2025-07-08 | ETST | Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | BUY | $0.18 | 33,044 | $5,938 | 1,700,000 |
| 2025-07-09 17:47 | 2025-07-07 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer | OPT+S | $5.67 | 6,500 | $36,855 | 0 |
| 2025-07-09 23:18 | 2025-07-07 | INSM | INSMED Inc | Bonstein Sara | Officer | OPT+S | $95.86 | 57,764 | $5,537,459 | 84,017 |
| 2025-07-09 00:55 | 2025-07-07 | BFRG | BullFrog AI Holdings, Inc. | Singh Vininder | Director, Officer, 10% owner | SELL | $1.50 | 29,002 | $43,625 | 2,292,446 |
| 2025-07-08 23:37 | 2025-07-07 | ALXO | Alx Oncology Holdings Inc. | Pinto Shelly | Officer | SELL | $0.45 | 2,011 | $905 | 86,809 |
| 2025-07-08 23:00 | 2025-07-03 | GLTO | Galecto, Inc. | Schambye Hans T. | Director, Officer | OPT+S | $3.38 | 735 | $2,484 | 4,022 |
| 2025-07-08 23:00 | 2025-07-03 | GLTO | Galecto, Inc. | Winslow Garrett | Officer | OPT+S | $3.39 | 260 | $881 | 1,429 |
| 2025-07-08 23:00 | 2025-07-03 | GLTO | Galecto, Inc. | Firmani Lori | Officer | OPT+S | $3.39 | 147 | $498 | 692 |
| 2025-07-09 03:19 | 2025-07-03 | IRON | Disc Medicine, Inc. | Quisel John D | Director, Officer | OPT+S | $55.09 | 5,200 | $286,454 | 161,828 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.